ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1296

Evaluating Inter-Rater Reliability in Joint Count to Promote Quality and Trust in a Clinical Arthritis Care Team

Diane Tin1, Lorna J. Bain1, J Carter Thorne2, Meen Jae Lee2,3, Lois Derrick1,4, E Jean Painter1, Annabelle Estaban1, Nooshin Samadi2, Sue Charette1, Sherry Hartnett1, Carolyn Bornstein1, Edward Ng2 and Michael Aubrey2, 1The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 2Southlake Regional Health Centre, Newmarket, ON, Canada, 3Pharmacology, McGill University, Montreal, QC, Canada, 4The Arthritis Society, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Assessment, Disease Activity, interdisciplinary rheumatology team, quality improvement and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Health Services Research Poster (ARHP)

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Joint count assessment is essential for the diagnosis and ongoing evaluation of Rheumatoid Arthritis (RA) disease activity. In our team based, interprofessional approach to arthritis care, the attending rheumatologist must be able to trust the joint count of fellow rheumatologists and allied health care providers (AHPs). Congruency and accuracy in joint count is imperative for effective collaboration to occur.

Inter-rater variability in assessing tender and swollen joint counts has been well documented, especially with a lack of consistency in swollen joint count (SJC), (ICC range 0.29 to 0.95)1.  As part of continuous quality improvement, we undergo annual joint count intervalidation.  In the Spring 2015, a joint count intervalidation event was held with all team members who routinely perform joint counts.  The aim of this study was two-fold: 1) to estimate the agreement between team members, and 2) to provide training for standardizing joint count assessments.  

Despite a growing interest to use patient-reported joint counts as an outcome measure, some argue (and we concur) that the physician/clinician joint count should remain the standard of care on which treatment decisions are based, and as such a joint count should be conducted at every visit.

Methods:

Ten assessors (4 rheumatologists, 2 physical therapists, 3 occupational therapists, 1 kinesiologist) and six patient volunteers with RA (2 diagnosed within past 12 months, 4 have longer term disease) attended the intervalidation session.  Patients were informed that the purpose of this event was quality assurance, not clinical care.  Assessors were instructed to be as objective as possible, by neglecting the historical comparison of joint status, and to measure counts based on swollen vs. not swollen.  All assessors and patient volunteers attended a debrief session afterwards when SJCs were compared and assessment techniques were discussed. A survey was administered to both assessors and patients to gather their feedback on the event.

Results:

Overall, inter-rater reliability between the 10 assessors on SJC for the 6 RA patients was moderate (ICC: 0.51, 95% CI: 0.30-0.91), with no difference between short and longer-term patients with RA (p>0.05).  Nonetheless, post-event questionnaires revealed that 100% of the rheumatologists and AHPs agreed or strongly agreed that intervalidation was a critical quality assurance initiative and a collaborative process for learning. All 4 rheumatologists reported increased confidence to co-manage RA patients with AHPs after attending the intervalidation session.

Conclusion:  

This is a unique quality assurance initiative designed to foster trust amongst a large interprofessional arthritis care team in a clinical care setting. In the framework of shared care and treat to target approaches, joint count intervalidation within networks of arthritis care providers may be valuable. Further research is necessary to identify opportunities to improve inter-rater agreement and more fully understand how assessor and patient-level factors may contribute to these findings.

  1. Cheung PP. et al: Reliability of joint count assessment in rheumatoid arthritis: A systemic literature review.  Semin Arthritis Rheum 2014; 43:721-9

Disclosure: D. Tin, None; L. J. Bain, None; J. C. Thorne, None; M. J. Lee, None; L. Derrick, None; E. J. Painter, None; A. Estaban, None; N. Samadi, None; S. Charette, None; S. Hartnett, None; C. Bornstein, None; E. Ng, None; M. Aubrey, None.

To cite this abstract in AMA style:

Tin D, Bain LJ, Thorne JC, Lee MJ, Derrick L, Painter EJ, Estaban A, Samadi N, Charette S, Hartnett S, Bornstein C, Ng E, Aubrey M. Evaluating Inter-Rater Reliability in Joint Count to Promote Quality and Trust in a Clinical Arthritis Care Team [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/evaluating-inter-rater-reliability-in-joint-count-to-promote-quality-and-trust-in-a-clinical-arthritis-care-team/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluating-inter-rater-reliability-in-joint-count-to-promote-quality-and-trust-in-a-clinical-arthritis-care-team/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology